A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

Clinical trial NCT07727538 · RECRUITING

Trial details

NCT number: NCT07727538
Sponsor: Ionis Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Familial Chylomicronemia Syndrome

Start date: 2026-07-31
Primary completion: 2030-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.